Home/Filings/4/0001062993-22-014133
4//SEC Filing

Nosenzo John 4

Accession 0001062993-22-014133

CIK 0001561921other

Filed

Jun 1, 8:00 PM ET

Accepted

Jun 2, 4:07 PM ET

Size

7.1 KB

Accession

0001062993-22-014133

Insider Transaction Report

Form 4
Period: 2022-06-01
Nosenzo John
Director
Transactions
  • Award

    Common Stock

    2022-06-01+3,1353,135 total
  • Award

    Stock Option (Right to Buy)

    2022-06-01+5,3605,360 total
    Exercise: $6.84Exp: 2032-06-01Common Stock (5,360 underlying)
Footnotes (2)
  • [F1]These restricted stock units vest on the earlier of (a) June 1, 2023, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Peron's continued service through the applicable vesting date.
  • [F2]The option vests on the earlier of (a) June 1, 2023, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Peron's continued service through the applicable vesting date.

Issuer

TELA Bio, Inc.

CIK 0001561921

Entity typeother

Related Parties

1
  • filerCIK 0001835973

Filing Metadata

Form type
4
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 4:07 PM ET
Size
7.1 KB